Advertisement

Topics

AstraZeneca

21:03 EDT 26th April 2018 | BioPortfolio

AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedicated to R&D. $4bn a year is also dedicated to R&D.

the main focus of their pharmaceutical research and production efforts is in cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation medications. 10 medications within these fields has individual sales of over $1bn each.

Source; BioPortfolio.com and AstraZeneca.com

Add the AsrtaZeneca News Channel to your RSS reader;

Follow the AstraZeneca Twitter feed; 

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy AstraZeneca market research data and corporate reports here